SARS-CoV-2
Managing physical and cognitive impairments in post-COVID-19 syndrome
Symptoms of post-COVID-19 syndrome changed little for nearly 1,000 individuals in their second year.
Surprising biological mechanisms discovered underlying severe COVID-19
Severe COVID-19 has been considered an inflammatory “cytokine storm”.
Study highlights specific changes associated with COVID-19 in particular brain function
Incorporating such sensitive cognitive testing into future studies could help reveal more detailed insights.
Spike mutations allow SARS-CoV-2 to enter the brain
A mutation in the SARS-CoV-2 virus helps it infect the brain, which could explain neurological issues like ‘long COVID.
Insights into COVID-19 cell entry may lead to improved vaccines
The viral spike protein suggests that future vaccines targeting it could work against various SARS-CoV-2 variants.
Routine tests fail to diagnose long-term COVID-19 accurately
An NIH-supported study published in the Annals of Internal Medicine found that routine lab tests aren't practical for diagnosing long COVID.
SARS-CoV-2 clues on pandemic potential
A Yale study found that two bat coronaviruses related to SARS-CoV-2, discovered in Laos, might not spread well in people despite their genetic similarities...
Easy flu tests may enhance diagnosis and tracking
CRISPR assays for quick flu detection and subtyping.
Targeting various COVID variants by altering spike protein structure
Versatile antiviral nanoparticles, effective across SARS-CoV-2 variants.
First SARS-CoV-2 vaccinations immune response to new virus variants
Immunological imprinting impacts human antibody reaction to SARS-CoV-2 mutations.
MIT researchers are using new nanoparticles to improve vaccines
Zeolitic imidazolate frameworks boost SARS-CoV-2 spike protein trimer immunity via Toll-like receptor activation.
Iron deficiency from infection may trigger long COVID
Iron imbalance and inflammatory stress affect COVID-19 outcomes.
Current antiviral treatment course is inadequate for high-risk COVID-19
Molnupiravir's impact on SARS-CoV-2 response in at-risk outpatients.
SARS-CoV-2 variants: How a set of key covariates affect viral kinetics?
A prospective observational cohort study.
Breakthrough RNA mapping method by HIRI researchers
SHIFTR allows unbiased protein identification on RNA regions in live cells.
The complement system damages cells in long-term COVID
Persistent complement dysfunction in long COVID: Inflammation and blood clot risks.
Influenza immunity spurs rapid protection in new vaccine
Influenza boosts antibody power against SARS-CoV-2.
How ultraviolet light degrades coronavirus?
SARS-CoV-2 has among the largest of genomes for RNA viruses.
COVID-19 changes gene activity in olfactory mucosal cells in Alzheimer’s
Distinct immune responses after infection between AD patients and healthy individuals.
SARS-CoV-2 moves within neurons to infect the brain
Separate effects: SARS-CoV-2, neuroinvasion, and anosmia.
COVID-19 vulnerability tied to past infections and vaccination
Mapping antigenic connections in SARS-CoV-2 and serological reactions.
A dive into the question of whether a COVID cure could lead to harmful mutations of the virus
A COVID cure worse than the disease?
COVID patients emit 1,000 virus copies per min in early symptoms
Exhaled SARS-CoV-2 RNA copies during COVID-19 infection.
COVID-19 virus is evolving rapidly in white-tailed deer
Study finds deer are virus reservoirs, promoting ongoing mutation.
Nose-picking healthcare workers were more likely to catch COVID-19 during the pandemic
Why not to pick your nose?
The genetic screen reveals protein for the COVID-19 vaccine
Tissue protein prevents viral spread and may provide COVID-19 defence.
Long COVID not caused by COVID-19 immune inflammatory response, study
Immune activation may persist for months after COVID-19.
Researchers develop deep learning model for predicting CRISPR tool activity
CRISPR and AI accurately control gene expression.
Probing the underlying mechanisms of immune dysfunction in Chronic lymphocytic leukemia
With a median age at diagnosis of 70 years, chronic lymphocytic leukemia (CLL) is the most common form of leukemia in Western nations and...